Spironolactone and Loss of taste for Women aged 50-59 (a phase IV clinical study of FDA data)

Summary:

Loss of taste is found for women aged 50-59 who take Spironolactone (spironolactone). This study is created by eHealthMe based on reports of 8,910 women aged 50-59 from the FDA, and is updated regularly. The information that eHealthMe analyzes includes:

Time on Spironolactone when people have Loss of taste
Top conditions
Top co-used drugs
Top other side effects

On Jul, 05, 2026

8,910 women aged 50-59 reported to have side effects when taking Spironolactone.
Among them, 38 people (0.43%) have Loss of taste

What is Spironolactone?

Spironolactone has active ingredients of spironolactone. It is often used in acne. eHealthMe is studying from 122,947 Spironolactone users. Check the latest studies of Spironolactone.

What is Loss of taste?

Loss of taste is found to be associated with 2,455 drugs and 3,129 conditions by eHealthMe. Check the latest studies of Loss of taste.

Number of reports submitted per year:

Could Spironolactone cause Loss of taste in women aged 50-59?

Time on Spironolactone when people have Loss of taste *

Severity of Loss of taste

n/a

How people recovered from Loss of taste

n/a

Top conditions involved for these people *:

You may use this to check any potential undetected conditions.

Stress And Anxiety: 3 people, 7.89%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 3 people, 7.89%
Type 2 Diabetes: 2 people, 5.26%
Swelling: 2 people, 5.26%
Asthma: 2 people, 5.26%
Quit Smoking: 2 people, 5.26%
Indigestion: 2 people, 5.26%
Multiple Myeloma (cancer of the plasma cells): 2 people, 5.26%
Fluid Retention (an abnormal accumulation of fluid in the blood): 1 person, 2.63%
Headache (pain in head): 1 person, 2.63%

Top co-used drugs for these people *:

You may use this to check any potential interacting drugs.

Top other side effects for these people *:

You may use this to check any potential undetected side effects.

Dizziness: 9 people, 23.68%
Nausea (feeling of having an urge to vomit): 8 people, 21.05%
Headache (pain in head): 8 people, 21.05%
Pain: 7 people, 18.42%
Dyspnea (difficult or laboured breathing): 7 people, 18.42%
Memory Loss: 6 people, 15.79%
Hypoaesthesia (reduced sense of touch or sensation): 6 people, 15.79%
Dry Mouth: 6 people, 15.79%
Muscle Spasms (muscle contraction): 6 people, 15.79%
Rashes (redness): 5 people, 13.16%

* Approximation only. Some reports may have incomplete information.

Do you take Spironolactone and have Loss of taste?

- Check whether Loss of taste is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies:

Spironolactone and Loss of taste

How the study uses the data?

The study is based on (applicable) gender, age, spironolactone (the active ingredients of Spironolactone) and Spironolactone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.